Edgewise Therapeutics Inc (NASDAQ: EWTX) started the day on Thursday, with a price decrease of -1.53% at $31.57, before settling in for the price of $32.06 at the close. Taking a more long-term approach, EWTX posted a 52-week range of $6.44-$38.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -68.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.38%. This publicly-traded company’s shares outstanding now amounts to $94.41 million, simultaneously with a float of $62.41 million. The organization now has a market capitalization sitting at $2.99 billion. At the time of writing, stock’s 50-day Moving Average stood at $32.25, while the 200-day Moving Average is $21.73.
Edgewise Therapeutics Inc (EWTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Edgewise Therapeutics Inc’s current insider ownership accounts for 34.09%, in contrast to 74.06% institutional ownership. According to the most recent insider trade that took place on Sep 20 ’24, this organization’s Chief Scientific Officer sold 75,000 shares at the rate of 28.27, making the entire transaction reach 2,120,101 in total value, affecting insider ownership by 12,719. Preceding that transaction, on Sep 20 ’24, Company’s General Counsel sold 50,000 for 28.37, making the whole transaction’s value amount to 1,418,510. This particular insider is now the holder of 3,252 in total.
Edgewise Therapeutics Inc (EWTX) Earnings and Revenue Records
Edgewise Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 5.38% and is forecasted to reach -1.83 in the upcoming year.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Let’s observe the current performance indicators for Edgewise Therapeutics Inc (EWTX). It’s Quick Ratio in the last reported quarter now stands at 26.35. The Stock has managed to achieve an average true range (ATR) of 1.67.
In the same vein, EWTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.49, a figure that is expected to reach -0.42 in the next quarter, and analysts are predicting that it will be -1.83 at the market close of one year from today.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
If we take a close look at the recent performances of Edgewise Therapeutics Inc (NASDAQ: EWTX), its last 5-days Average volume was 0.73 million that shows plunge from its year to date volume of 0.93 million. During the previous 9 days, stock’s Stochastic %D was recorded 37.90% While, its Average True Range was 1.66.
Raw Stochastic average of Edgewise Therapeutics Inc (EWTX) in the period of the previous 100 days is set at 71.65%, which indicates a major rise in contrast to 42.05% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 33.40% that was lower than 89.87% volatility it exhibited in the past 100-days period.
